LifePulse Bioscience
The Leader in Providing Next Gen Technology in Enhanced Molecular Delivery Science
LifePulse is a wholly owned subsidiary of MMD Technologies LLC. MMD was founded in a quest to bring meaningful change to an old technology that would bring it into the mainstream and standard of care for the first time by greatly reducing the potential for tissue damage and assuring delivery of the therapeutic. MMD is the beneficiary of $33M of grant research dollars over 25 years to create the series of patents that make these important changes.
We are pleased to be the first to engineer and produce the finest medical instrument in the field right here in the USA with a three-year warranty and world-class service.
Watch Our Video
Our Team
Gary Strange
Chief Executive Officer
Gary Strange has more than 20 years experience guiding companies from start-up to successful launch and acquisition and has an extensive background in quantitative modeling, valuation and exit planning.
Rick Flath
Chief Corporate Strategist
Rick Flath is a corporate strategist for MMD. He has successfully been involved from research concepts, licensing, funding strategy through commercialization.
Rommie Ray
Advisory Council
Rommie Ray has an extensive background in science, pharmaceuticals and business and has been with Astra Zeneca in seniot positions for more than a decade.
Dr. Richard Heller
Chief Science Officer
Dr. Richard Heller is a teaching professor at the University of South Florida and a member of the USF Health team. Together, Dr. Richard Heller and Dr. Mark Jaroszeski have combined for over 100 patents.
Dr. Mark Jaroszeski
Vice President, Research
Dr. Mark Jaroszesk is a teaching professor at the University of South Florida and a member of the USF Health team. Together, Dr. Mark Jaroszeski and Dr. Richard Heller have combined for over 100 patents.
Our Advisors
David Baker
Managing Director
Roger Kahn
Managing Director
Jonathan Lourie, JD
Life Sciences Group Team Lead
